A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)
Clinical trial NCT06662396 · COMPLETED
Trial details
- NCT number
- NCT06662396
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-13
- Primary completion
- 2024-09-27
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.